相关实验视频
Updated: Sep 12, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
欧洲小儿心脏病学单位的血栓预防实践
Ciara Ryan1, Michal Odermarsky2, Daniel De Wolf3
1Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin 12, D12 N512, Ireland.
European journal of pediatrics
|August 5, 2025
概括
欧洲的儿童心脏病中心展示了预防心脏病儿童血栓的各种做法. 这凸显了需要统一的,基于证据的指导方针,特别是关于新的口服抗凝剂.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 血栓形成的管理
背景情况:
- 患有先天性和获得性心脏病的儿童在手术后面临更高的血栓形成风险.
- 现有的国际指南涵盖了儿科心脏病患者的抗血小板和抗凝管理.
研究的目的:
- 评估欧洲儿科心脏病单位当前的血栓预防处方实践.
- 为了识别儿童和先天性心脏病患者的血栓形成风险管理的变化.
主要方法:
- 一项在线调查分发给了27个与AEPC关联的欧洲儿心脏病中心.
- 从30名参与者那里收集了有关血栓预防策略的答案.
主要成果:
- 在不同患者群体 (例如单心室,干预后,心肌病) 中,血栓预防方法存在显著差异.
- 观察到的迹象,药物选择和治疗时间的差异是对血栓预防的治疗时间.
结论:
- 目前在欧洲的临床实践表明,小儿心脏病患者的血栓预防有相当大的异质性.
- 显然需要基于证据的指导方针来规范护理,并纳入新型抗凝剂.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K

